Comments on: Risk of dyslipidemia in chronic hepatitis B patients taking tenofovir alafenamide: a systematic review and meta-analysis
Crossref DOI link: https://doi.org/10.1007/s12072-024-10642-0
Published Online: 2024-03-02
Published Print: 2024-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Wang, Yan
Sun, Xiu
Zhang, Junyan http://orcid.org/0000-0002-7890-3707
Mei, Qi
Text and Data Mining valid from 2024-03-02
Version of Record valid from 2024-03-02
Article History
Received: 18 December 2023
Accepted: 10 January 2024
First Online: 2 March 2024
Declarations
:
: All authors have no conflict of interest to disclose.